Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study (Breast Cancer, (2022), 29, 1, (92-102), 10.1007/s12282-021-01283-4)

Su Jin Koh, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, Ming Shen Dai, Chuan Hsun Chang, Tapashi Dalvi, Graham Walker, James Bennett, Joyce O’Shaughnessy, Judith Balmaña

研究成果: ジャーナルへの寄稿コメント/討論

1 被引用数 (Scopus)

抄録

The article “Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study”, written by Su Jin Koh, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, Ming Shen Dai, Chuan Hsun Chang, Tapashi Dalvi, Graham Walker, James Bennett, Joyce O’Shaughnessy, Judith Balmaña, was originally published electronically on the publisher’s internet portal on 31 August 2021 without open access.

本文言語英語
ページ(範囲)189-190
ページ数2
ジャーナルBreast Cancer
29
1
DOI
出版ステータス出版済み - 2022 1月

フィンガープリント

「Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study (Breast Cancer, (2022), 29, 1, (92-102), 10.1007/s12282-021-01283-4)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル